These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 8334526)

  • 21. Differential effects of 5-HT agonists and antagonists on the repeated acquisition and performance of response sequences in monkeys.
    Winsauer PJ; Moerschbaecher JM
    Behav Pharmacol; 2000 Nov; 11(7-8):535-53. PubMed ID: 11198126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological profile of (-)HT-90B, a novel 5-HT1A receptor agonist/5-HT2 receptor antagonist.
    Uchida H; Inagawa K; Tameda C; Miyauchi T
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Nov; 19(7):1201-16. PubMed ID: 8787043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of long-term treatment with the 5-HT1A receptor agonist 8-OH-DPAT and the 5-HT2/1C receptor agonist DOI in the neonatal rat.
    Johansson-Wallsten CE; Berg M; Meyerson BJ
    Eur J Pharmacol; 1993 Oct; 243(2):149-54. PubMed ID: 8276064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central administration of 5-HT activates 5-HT1A receptors to cause sympathoexcitation and 5-HT2/5-HT1C receptors to release vasopressin in anaesthetized rats.
    Anderson IK; Martin GR; Ramage AG
    Br J Pharmacol; 1992 Dec; 107(4):1020-8. PubMed ID: 1467825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agonist action at 5-HT1C receptors facilitates 5-HT1A receptor-mediated spontaneous tail-flicks in the rat.
    Bervoets K; Millan MJ; Colpaert FC
    Eur J Pharmacol; 1990 Nov; 191(2):185-95. PubMed ID: 2150818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
    de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Desensitization of 5-HT1A receptors by 5-HT2A receptors in neuroendocrine neurons in vivo.
    Zhang Y; Gray TS; D'Souza DN; Carrasco GA; Damjanoska KJ; Dudas B; Garcia F; Zainelli GM; Sullivan Hanley NR; Battaglia G; Muma NA; Van de Kar LD
    J Pharmacol Exp Ther; 2004 Jul; 310(1):59-66. PubMed ID: 15064330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioural response to pharmacologic manipulation of serotonin receptors in the genetically dystonic hamster.
    Richter A; Löscher W
    Pharmacol Biochem Behav; 1995 Dec; 52(4):655-65. PubMed ID: 8587901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long lasting attenuation of 8-OH-DPAT-induced corticosterone secretion after a single injection of a 5-HT1A receptor agonist.
    Kelder D; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Aug; 346(2):121-6. PubMed ID: 1448177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypothalamic paraventricular nucleus lesions differentially affect serotonin-1A (5-HT1A) and 5-HT2 receptor agonist-induced oxytocin, prolactin, and corticosterone responses.
    Bagdy G; Makara GB
    Endocrinology; 1994 Mar; 134(3):1127-31. PubMed ID: 8119151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of selective 5-HT1A agonists and 5-HT2 antagonists on inherited catalepsy in rats.
    Kulikov AV; Kolpakov VG; Maslova GB; Kozintsev I; Popova NK
    Psychopharmacology (Berl); 1994 Feb; 114(1):172-4. PubMed ID: 7846200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm.
    Millan MJ; Rivet JM; Gobert A; Canton H; Veiga S; Bervoets K
    J Pharmacol Exp Ther; 1994 Apr; 269(1):121-31. PubMed ID: 7909555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-HT1A and muscarinic acetylcholine receptors jointly regulate passive avoidance behavior.
    Riekkinen P
    Eur J Pharmacol; 1994 Sep; 262(1-2):77-90. PubMed ID: 7813581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
    Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
    J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central 5-HT1A receptors inhibit adrenocortical secretion.
    Welch JE; Farrar GE; Dunn AJ; Saphier D
    Neuroendocrinology; 1993; 57(2):272-81. PubMed ID: 8510803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BIMT 17, a 5-HT1A receptor agonist/5-HT2A receptor antagonist, directly activates postsynaptic 5-HT inhibitory responses in the rat cerebral cortex.
    Borsini F; Ceci A; Bietti G; Donetti A
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Sep; 352(3):283-90. PubMed ID: 8584043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of 5-HT agonists, selective for different receptor subtypes, on oxytocin, CCK, gastrin and somatostatin plasma levels in the rat.
    Uvnäs-Moberg K; Hillegaart V; Alster P; Ahlenius S
    Neuropharmacology; 1996; 35(11):1635-40. PubMed ID: 9025112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat.
    Dreteler GH; Wouters W; Saxena PR
    Eur J Pharmacol; 1990 May; 180(2-3):339-49. PubMed ID: 2142096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for involvement of 5-HT1C and 5-HT2 receptors in the food intake suppressant effects of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI).
    Aulakh CS; Hill JL; Yoney HT; Murphy DL
    Psychopharmacology (Berl); 1992; 109(4):444-8. PubMed ID: 1365860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The serotonin 5-HT2 receptor-phospholipase C system inhibits the induction of long-term potentiation in the rat visual cortex.
    Edagawa Y; Saito H; Abe K
    Eur J Neurosci; 2000 Apr; 12(4):1391-6. PubMed ID: 10762367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.